Suppr超能文献

射血分数保留的心力衰竭中的年龄和性别差异。

Age and Sex Differences in Heart Failure With Preserved Ejection Fraction.

作者信息

Kobak Kamil Aleksander, Zarzycka Weronika, Chiao Ying Ann

机构信息

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.

出版信息

Front Aging. 2022 Feb 15;3:811436. doi: 10.3389/fragi.2022.811436. eCollection 2022.

Abstract

Heart failure with preserved ejection fraction (HFpEF) is a multi-organ disorder that represents about 50% of total heart failure (HF) cases and is the most common form of HF in the elderly. Because of its increasing prevalence caused by the aging population, high mortality and morbidity, and very limited therapeutic options, HFpEF is considered as one of the greatest unmet medical needs in cardiovascular medicine. Despite its complex pathophysiology, numerous preclinical models have been established in rodents and in large animals to study HFpEF pathophysiology. Although age and sex differences are well described in HFpEF population, there are knowledge gaps in sex- and age-specific differences in established preclinical models. In this review, we summarize various strategies that have been used to develop HFpEF models and discuss the knowledge gaps in sex and age differences in HFpEF.

摘要

射血分数保留的心力衰竭(HFpEF)是一种多器官疾病,约占心力衰竭(HF)病例总数的50%,是老年人中最常见的HF形式。由于人口老龄化导致其患病率不断上升、死亡率和发病率高,以及治疗选择非常有限,HFpEF被认为是心血管医学中最大的未满足医疗需求之一。尽管其病理生理学复杂,但已经在啮齿动物和大型动物中建立了许多临床前模型来研究HFpEF的病理生理学。虽然HFpEF人群中的年龄和性别差异已有充分描述,但在已建立的临床前模型中,性别和年龄特异性差异方面仍存在知识空白。在本综述中,我们总结了用于开发HFpEF模型的各种策略,并讨论了HFpEF中性别和年龄差异方面的知识空白。

相似文献

1
Age and Sex Differences in Heart Failure With Preserved Ejection Fraction.
Front Aging. 2022 Feb 15;3:811436. doi: 10.3389/fragi.2022.811436. eCollection 2022.
2
Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models.
JACC Basic Transl Sci. 2022 May 25;7(8):844-857. doi: 10.1016/j.jacbts.2021.12.009. eCollection 2022 Aug.
3
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30.
5
Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?
Front Physiol. 2022 Jul 8;13:906272. doi: 10.3389/fphys.2022.906272. eCollection 2022.
6
Heart failure with preserved ejection fraction in the elderly: scope of the problem.
J Mol Cell Cardiol. 2015 Jun;83:73-87. doi: 10.1016/j.yjmcc.2015.02.025. Epub 2015 Mar 6.
7
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
J Am Coll Cardiol. 2019 Dec 10;74(23):2858-2873. doi: 10.1016/j.jacc.2019.09.063.
9
Evaluation of large animal models for preclinical studies of heart failure with preserved ejection fraction using clinical score systems.
Front Cardiovasc Med. 2023 Mar 23;10:1099453. doi: 10.3389/fcvm.2023.1099453. eCollection 2023.
10
Heart Failure with Preserved Ejection Fraction: the Major Unmet Need in Cardiology.
Korean Circ J. 2020 Dec;50(12):1051-1061. doi: 10.4070/kcj.2020.0338. Epub 2020 Sep 15.

引用本文的文献

1
S-nitrosylation of cardiac myocyte proteins may underlie sex differences in cardiac disease.
Front Physiol. 2025 May 6;16:1565917. doi: 10.3389/fphys.2025.1565917. eCollection 2025.
3
Identifying sex similarities and differences in structure and function of the sinoatrial node in the mouse heart.
Front Med (Lausanne). 2024 Dec 5;11:1488478. doi: 10.3389/fmed.2024.1488478. eCollection 2024.
4
Juvenile physical activity protects against isoproterenol-induced cardiac dysfunction later in life.
J Appl Physiol (1985). 2023 Sep 1;135(3):572-583. doi: 10.1152/japplphysiol.00010.2023. Epub 2023 Jul 13.
6
Adverse cardiovascular and metabolic perturbations among older women: 'fat-craving' hearts.
Clin Res Cardiol. 2023 Nov;112(11):1555-1567. doi: 10.1007/s00392-023-02156-w. Epub 2023 Jan 18.

本文引用的文献

1
Molecular Signature of HFpEF: Systems Biology in a Cardiac-Centric Large Animal Model.
JACC Basic Transl Sci. 2021 Aug 23;6(8):650-672. doi: 10.1016/j.jacbts.2021.07.004. eCollection 2021 Aug.
2
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
3
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
5
NAD Repletion Reverses Heart Failure With Preserved Ejection Fraction.
Circ Res. 2021 May 28;128(11):1629-1641. doi: 10.1161/CIRCRESAHA.120.317046. Epub 2021 Apr 22.
7
Novel Göttingen Miniswine Model of Heart Failure With Preserved Ejection Fraction Integrating Multiple Comorbidities.
JACC Basic Transl Sci. 2021 Feb 3;6(2):154-170. doi: 10.1016/j.jacbts.2020.11.012. eCollection 2021 Feb.
8
Cellular and molecular pathobiology of heart failure with preserved ejection fraction.
Nat Rev Cardiol. 2021 Jun;18(6):400-423. doi: 10.1038/s41569-020-00480-6. Epub 2021 Jan 11.
9
Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF.
Circ Res. 2021 Jan 22;128(2):232-245. doi: 10.1161/CIRCRESAHA.120.317933. Epub 2020 Nov 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验